| ADHD | ||
 | ||
 | ||
|
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurological condition related, in part, to the brain's chemistry and anatomy. ADHD manifests itself as a persistent pattern of inattention and/or hyperactivity/impulsivity that occurs more frequently and more severely than is typically observed in people at comparable levels of development. ADHD begins in childhood and can persist into adulthood as well. While some children outgrow ADHD, about 60% continue to have symptoms into adulthood. It is estimated that between 3 and 5 percent of children have ADHD, or approximately 2 million children in the United States. It is estimated that 23 million children and adolescents in the seven major markets suffer from ADHD, a figure that is growing constantly. Currently, the US market is projected at over $3.0 billion. While it is difficult to put an exact number on the adult patient population, it is inherently larger than that of children and adolescents - comprised of patients previously diagnosed with pediatric ADHD in addition to patients who have only recently been diagnosed with adult ADHD. While over 20 million children globally have been diagnosed with ADHD, it is estimated that only 5-10% of children suffering are ever actually diagnosed. ADHD Programs SPN812:
|
|
